Clinical trials

33

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Right-Size Clinic Visits Using Memora Platform for PROMIS

Developing novel methods of patient communication is crucial in providing value-based care to orthopedic patients. Healthcare technology platforms have been developed to improve patient communication methods particularly for the administration of patient-reported outcome measures (PROMs). However, the majority of these interventions rely on web-based platforms that require patients to have computer access. Among American households earning less than $30,000 per year, only 59% have access to a desktop or laptop and just 47% have broadband internet at home compared to mobile phone penetration which is estimated at 95% of which 93% regularly use text messages. The use of phone messaging may be the most effective means to have patients complete PROMs. The Patient-Reported Outcomes Measurement Information System (PROMIS) is an NIH-funded, clinically validated method of tracking patient-reported outcomes to efficiently assess patient health status. PROMIS utilizes Item Response Theory (IRT) and computerized adaptive testing (CAT) to improve measurement precision and decrease survey time as compared to traditional PROMs. The purpose of this two-phase study is to utilize Memora Health's text-messaging platform to collect web-based PROMIS CAT surveys from patients (Phase 1) and use this information to right-size clinic visits (Phase 2).

Participants needed: 3,000
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Oct 7, 2026Locations: 1
Eligibility criteria

Ankle Fracture [+13]

Limited and non-readers [+2]

Status: Not yet recruiting

A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk Aim 3

Between 2015 and 2019, overdose deaths translated to 1.25 million years of life lost among adolescents and young adults (youth) aged 12 to 24 years, and the percent change in fatal overdose rates among adolescents ages 14 to 18 was higher than adults between 2019 and 2020.3-5 Primary care providers are uniquely positioned to provide evidence-based information to youth to both improve awareness of overdose risk (individual benefit) and simultaneously ensure that youth are prepared to recognize and respond to an overdose (public health benefit). However, currently there is no evidence-based intervention for pediatric primary care to reduce youth overdose risk and ensure youth can recognize and respond to an overdose. To address the gap in evidence-based overdose prevention interventions for youth, the investigators propose a randomized controlled trial (RCT) to evaluate the efficacy of a brief universal overdose prevention intervention in pediatric primary care. 24 providers and 624 youth patient participants randomized (at the provider level) to receive either the brief overdose prevention intervention or usual care will be enrolled.

Participants needed: 648
Trial details
Age: 13+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Oct 1, 2026Locations: 1
Eligibility criteria

Physicians and advance practice providers (nurse practitioners and physician ass... [+4]

Participated as an intervention provider in the R61 pilot RCT (H-45731) [+7]

Status: Recruiting

Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.

Participants needed: 50
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Oct 1, 2026Locations: 1
Eligibility criteria

ESRD (end stage renal disease) patients at BMC (Boston Medical Center) [+3]

None

Status: Not yet recruiting

Heart Failure Self Care Education in Rwanda

In Rwanda, patients with heart failure may have low health education about their condition. Heart failure care requires active patient involvement. Self-care of heart failure requires healthy lifestyle, attention to symptoms, proper action when new symptoms develop. However, many patients may choose to stop taking medications when they are feeling well, or disregard new symptoms when they develop and delaying care until their condition is more severe. Educating patients in self-care for heart failure can be achieved by clinical staff with the support of patient handbooks or flip books. Self-care education materials have been developed by the research team in Haiti and have been adapted for Rwanda. This study will use a cluster, stepped wedge design. Patients are already in clusters based on their health facility. The order of implementation will be randomized by the cluster. The primary outcome is heart failure knowledge assessed pre- and post-intervention through a structured survey.

Participants needed: 400
Trial details
Age: 10+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Sep 30, 2026Locations: 1
Eligibility criteria

Participants living with heart failure followed at non-communicable disease clin... [+2]

Unable to provide informed consent

Status: Not yet recruiting

HERE: Health Empowerment and Resources After Pregnancy

This study will examine whether a patient navigation program can help improve long-term heart health among people who experienced high blood pressure disorders during pregnancy at Boston Medical Center (BMC). Conditions such as preeclampsia and other hypertensive disorders of pregnancy increase a person's risk of developing cardiovascular disease later in life. However, many patients do not receive timely follow-up care after pregnancy, especially once routine postpartum care ends. about 60 participants will be randomly assigned to one of two groups. One group will receive standard care, which includes clinician-directed counseling about cardiovascular risk and recommendations for follow-up care. The other group will receive support from a patient navigator in addition to standard care. Patient navigators, also known as Community Wellness Advocates (CWAs), are trained staff who help patients connect with health services, understand their health risks, and navigate the healthcare system. The main goals of the study are to determine whether this navigation program is practical to implement and acceptable to patients and healthcare providers. Researchers will also examine whether the program improves follow-up with primary care, cardiovascular risk assessment, and engagement in heart-healthy behaviors. Information will be collected from medical records, surveys, and interviews with participants and healthcare staff. Participants will be followed for one year

Participants needed: 60
Trial details
Age: 23+Biological sex: FemaleType: InterventionalSponsor: Boston Medical CenterUpdated: Sep 29, 2026Locations: 1
Eligibility criteria

Gave birth at Boston Medical Center (BMC) in the past 2 months [+5]

Diagnosed with cardiovascular disease [+2]

Status: Not yet recruiting

Cardiac Anodal Biphasic Pacing

The goal of this study is to test a new pacing method called anodal biphasic pacing (ABP) to determine if this pacing works as well-or better-than current pacing methods. This new method may improve how the heart works and reduce some of the problems caused by regular pacing. Current implantable pacemakers use a monophasic cathodal waveform to stimulate the heart. Monophasic cathodal pacing (MCP) waveforms slow conduction, impair contractility, cause inflammation, increase risk of atrial fibrillation, heart failure, and mortality. Anodal biphasic pacing (ABP) is an alternative waveform that can stimulate the heart. ABP preconditions the heart and then initiates cardiac contraction. ABP may address the limitations of MCP.

Participants needed: 108
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Sep 29, 2026Locations: 1
Eligibility criteria

Planned generator exchange of dual chamber cardiac implantable electronic device... [+3]

Permanent atrial fibrillation [+7]

Status: Not yet recruiting

Boston Medical Center Ultrasound Decongestion Study in Heart Failure

The purpose of this study is to analyze the utility of a novel five-point ultrasound as a predictor of volume overload in diverse patients who are admitted with volume overload/congestive heart failure (CHF) exacerbation at Boston Medical Center (BMC), the largest safety-net hospital in New England. Current standard of care (SOC) involves the utilization of laboratory markers and physical exam, which is often inconsistent and equivocal. The investigators will assess will assess if ultrasound-assisted diuresis reduces recurrent episodes of volume overload/decompensated heart failure.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Sep 29, 2026Locations: 1
Eligibility criteria

Patient with a primary diagnosis of acute on chronic decompensated heart failure... [+2]

Hemodynamic instability defined as systolic blood pressure <85 mmHg or mean arte... [+11]

Status: Recruiting

Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication classes. Successful HTN management requires ongoing patient engagement for BP monitoring and treatment intensification. Reaching this goal is challenging, and many patients with HTN do not have controlled BP. Using a collaborative partnership between patients, clinicians, health system and public health stakeholders, and the research team the investigators plan to overcome barriers to widespread implementation of evidence-based health system strategies to improve BP control in a large, urban, primary care-based safety-net setting for diverse populations experiencing disparities in HTN-related outcomes.

Participants needed: 16,895
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Sep 30, 2026Locations: 7
Eligibility criteria

Adult (age>18) patients receiving primary care at one of the 9 participating sit... [+2]

Not meeting the inclusion criteria

Status: Recruiting

Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents

This study aims to improve retention in buprenorphine treatment, a medication used for opioid use disorder, through the use of a smartphone-delivered recovery support intervention. The intervention involves an Embodied Conversational Agent (ECA), a virtual, animated computer agent designed to simulate natural face-to-face conversations. ECAs have been shown to help individuals manage their healthcare in other settings, and this study seeks to evaluate their potential in supporting patients on medication for opioid use disorder (MOUD).

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Sep 30, 2026Locations: 1
Eligibility criteria

Diagnosis of Opioid Use Disorder (OUD) [+6]

Incarceration anticipated within 12 months of enrollment [+2]

Status: Recruiting

Non-Invasive Monitoring Methods in Patients With Acute Brain Injury

Life-threatening mass effect (LTME) arises when brain swelling displaces or compresses crucial midline structures subsequent to acute brain injuries (ABIs) like traumatic brain injury (TBI), ischemic stroke (IS), and intraparenchymal hemorrhage (IPH), which can manifest rapidly within hours or more gradually over days. Despite advancements in surgical management, significant gaps in understanding persist regarding optimal monitoring and therapeutic approaches. The current standard for identifying LTME involves neurologic decline in conjunction with radiographic evidence or increased intracranial pressure (ICP) indicating space-occupying mass effect. However, in critically ill patients, reliance on subjective physical exam findings, such as decreased arousal, often leads to delayed recognition, occurring only after catastrophic shifts have already occurred. The goal of this study is to determine the association of non-invasive biomarkers with neurologic deterioration, and to determine whether non-invasive biomarker inclusion improves detection of outcome and decline. The investigators propose to use various non-invasive methods to monitor ICP as adjuncts in detecting deteriorating mass effect. These methods include quantitative pupillometry, radiographic data, laboratory data, and other bedside diagnostic tests available including electroencephalography (EEG), skull vibrations detected via brain4care device, optic nerve sheath diameter assessment (ONSD), and ultrasound-guided eyeball compression. Some of these methods will be measured \*only\* for the purposes of the research study (such as skull vibrations via brain4care). Other measurements, such as quantitative pupillometry, will represent additional measurements beyond those already being collected for clinical care. This research study is necessary to understand the association of these non-invasive biomarkers with neurological decline and outcomes while considering potential confounding factors.

Participants needed: 720
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Boston Medical CenterUpdated: Sep 30, 2026Locations: 1
Eligibility criteria

Admitted under Neuro intensivist primary or consultative care. [+4]

Comfort measure only [+5]

Status: Recruiting

Nutrition in Patient With Critical Limb Ischemia

A prospective pilot study examining nutritional supplements among vascular surgery patients with Critical Limb Ischemia (CLI). CLI patients have a high rate of malnutrition and has the potential to benefit greatly from nutritional intervention. The investigators plan to evaluate nutrition and functional status of patients by assessing objective lab values and the use of the hand grip strength test. Providing perioperative nutritional supplements to patients has potentially improved their nutritional status, which in turn may improve the patient's clinical status after surgery.

Participants needed: 30
Trial details
Phase: Early Phase 1Age: 18-99Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Sep 29, 2026Locations: 1
Eligibility criteria

Critical Limb Ischemia

Female patients who are pregnant or lactating [+2]

Status: Not yet recruiting

Health-Related Social Needs Food Boxes Delivery Program

Nourishing At Home: Health-Related Social Needs Food Boxes Delivery Program is a pilot intervention study evaluating whether home delivery of medically tailored food boxes can reduce food insecurity and improve health outcomes among pediatric families including caregiver physical and mental health, child physical health, and overall family well-being.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Sep 1, 2026Locations: 1
Eligibility criteria

Participant has a child younger than 18 years seen by the Boston Medical Center... [+3]

High-risk adolescent pregnancy [+1]

Status: Recruiting

BoTox Into the Sternocleidomastoid Muscles (SCM)

Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimming effect on the neck and produce a more feminine, youthful neck contour.

Participants needed: 30
Trial details
Phase: Phase 4Age: 18-65Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Aug 31, 2026Locations: 1
Eligibility criteria

Age eligible individual seeking a more feminine neck appearance

Prior neuromodulator injections in the sternocleidomastoid muscles (SCM) within... [+5]

Status: Not yet recruiting

Glaucoma Drop Aids Part 2

Glaucoma medications are vital to disease management and prevention of further loss of vision as over time glaucoma will lead to irreversible blindness. The average size of a glaucoma medication bottle is around 10cc and these medications when used 2-3 times daily are expected to last patients an entire month. The investigators found that at Boston Medical Center (BMC) a majority of Yawkey Eye Clinic patients are unable to deliver the drops into their eyes due to poor vision or difficulty squeezing drop bottles. These patients also often deliver more than a necessary amount leading to premature completion of the bottle. However, because the cost benefit ratio of these drop aids is unclear, they are not routinely offered to the patients. Although the efficacy of these drop aids has not been well studied, if effective, the cost of these drop aids would more than pay themselves by improving medication compliance and visual function of the patients. This study aims to determine the efficacy of the Nanodropper in the BMC Yawkey Eye Clinic patient population.

Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Jul 28, 2026Locations: 1
Eligibility criteria

Currently on the same topical ophthalmic medications for treatment of glaucoma f... [+1]

Changed glaucoma medications within the past 2 months

Status: Not yet recruiting

Anti-Interleukin-6 (IL6) in Calciphylaxis

Calciphylaxis is a rare but incredibly dangerous condition that causes small blood vessels in the skin to become blocked by calcium buildup and blood clots. This leads to painful skin sores (necrosis) that do not heal easily. Because these open wounds are prone to severe infections, the outlook for patients is often grim; more than half of those diagnosed do not survive past the first year. Currently, there are no Food and Drug Administration (FDA) approved medications specifically designed to stop the progression of this disease. However, recent research has identified a specific culprit: Interleukin-6 (IL-6). The research team is looking at a drug called Tocilizumab to turn off the progression of the disease. This project aims to investigate whether Tocilizumab can consistently stop the cycle of inflammation and clotting, providing a much-needed lifeline for patients facing this life-threatening diagnosis. Ten participants with calciphylaxis and end-stage kidney disease will be enrolled to receive 3 infusions of Tocilizumab, follow-ups on a weekly basis, during their trip to the dialysis unit, for a total of 16 weeks.

Participants needed: 10
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Jul 16, 2026Locations: 1
Eligibility criteria

Must have a clinical diagnosis of calciphylaxis (calcific uremic arteriolopathy)... [+7]

Presence of any active, clinically significant infection (bacterial, viral, fung... [+16]

Status: Recruiting

Stepped Care for Posttraumatic Stress Disorder Study

Less than 20% of people with PTSD receive any treatment. This study extends a program of research by the investigator focused on developing adaptive (stepped) interventions for PTSD. The adaptive intervention sequences a digital mental health intervention (DMHI) and brief trauma- and skills-focused treatments for PTSD. The selected treatments are brief and scalable and less burdensome to systems of care. These treatments are: web-administered Skills Training in Affective and Interpersonal Regulation (webSTAIR), Brief STAIR, and Written Exposure Therapy (WET).

Participants needed: 428
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Jul 14, 2026Locations: 1
Eligibility criteria

Boston Medical Center primary care patient [+8]

Patient is not clinically appropriate for outpatient level of care. [+1]

Status: Recruiting

Behavior Analytic Support of Needle-related Hospital Visits for Autistic Patients

The purpose of this study is to evaluate the effectiveness of the behavior analytic intervention in reducing the number of challenging behaviors exhibited by patients with Autism Spectrum Disorder (ASD) while increasing compliance with needle-related simulations and procedures. A second purpose is to assess the social validity of this study as evidenced by patient and/or caregiver acceptability. The study wil take place at Boston Medical Center (BMC). A Single Subject Design (SSD) wil be utilized as it allows for detailed, individualized assessment of how interventions affect behavior over time in this type of behavior analytic research. By focusing on each participant as an individual and having each participant act as their own control, it demonstrates clear cause-and-effect relationships, showing how behavior changes with the introduction or withdrawal of an intervention. This method is flexible, enabling ongoing adjustments to treatments based on real-time data, making it particularly useful in personalized interventions and ensuring effectiveness for patients with unique needs such as those who would be eligible to enroll and participate in this study.

Participants needed: 10
Trial details
Age: 3+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Jul 9, 2026Locations: 1
Eligibility criteria

Caregivers of autistic patients who have been historically engaged in challengin... [+3]

Patients who are unable to visit BMC a minimum of 2 times per month [+2]

Status: Recruiting

Cervical Preparation for Same-Day Dilation & Evacuation

This is a noninferiority randomized control trial of two cervical preparation methods prior to same-day Dilation \& Evacuation (D\&E). Cervical preparation is a process that softens and dilates the cervix prior to a procedure. The primary objective is to evidence noninferiority of cervical preparation using a single-balloon catheter method when compared to a group receiving osmotic dilators, specifically in D\&E operative time. Secondary objectives will compare the two methods for adequate dilation, ability to complete the operation in the same day, participant pain, satisfaction and safety.

Participants needed: 32
Trial details
Age: 16+Biological sex: FemaleType: InterventionalSponsor: Boston Medical CenterUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Between 16 weeks 0 days - 18 weeks 6 days gestational age who are pursuing termi... [+3]

Allergy to betadine, aquacryl hydrogel, latex-free silicone single-balloon cathe... [+4]

Status: Recruiting

Simulation Trial of Telemedical Support for Paramedics

In the United States, the current standard of prehospital (i.e. outside of hospitals) emergency care for children with life-threatening illnesses in the community includes remote physician support for paramedics providing life-saving therapy while transporting the child to the hospital. Most prehospital emergency medical services (EMS) agencies use radio-based (audio only) communication between paramedics and physicians to augment this care. However, this communication strategy is inherently limited as the remote physician cannot visualize the patient for accurate assessment and to direct treatment. The purpose of this pilot randomized controlled trial (RCT) is to evaluate whether use of a 2-way audiovisual connection with a pediatric emergency medicine expert (intervention = "telemedical support") will improve the quality of care provided by paramedics to infant simulator mannequins with life threatening illness (respiratory failure). Paramedics receiving real-time telemedical support by a pediatric expert may provide better care due to decreased cognitive burden, critical action checking, protocol verification, and error correction. Because real pediatric life-threatening illnesses are rare, high stakes events and involve a vulnerable population (children), this RCT will test the effect of the intervention on paramedic performance in simulated cases of pediatric medical emergencies. The two specific aims for this research are: * Aim 1: To test the intervention efficacy by determining if there is a measurable difference in the frequency of serious safety events between study groups * Aim 2: To compare two safety event detection methods, medical record review, and video review

Participants needed: 420
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Jun 30, 2026Locations: 9
Eligibility criteria

Certified Emergency Medical Technicians (EMTs), Advanced EMTs (AEMTs), and Param... [+2]

EMS personnel providing interfacility transport and/or pediatric specialty trans... [+2]

Status: Recruiting

Integrative Mindfulness-Based Predictive Approach for Chronic Low Back Pain Treatment

This study will identify unique signatures that people have which can cause pain by evaluating biological, psychological, and social markers using artificial intelligence. These markers can be used to accurately predict the response of diverse individuals with chronic low back pain (cLBP) to Mindfulness-Based Stress Reduction. This will help enhance clinician decision-making and the targeted treatment of chronic pain. The overall objective is to use a unique machine learning (ML) approach to determine the biomarker signature of persons undergoing mindfulness based stress reduction (MBSR) treatment for their chronic low back pain (cLBP). This signature will facilitate clinical prediction and monitoring of patient response to MBSR treatment. The design of the study is a single-arm clinical trial of the evidence-based MBSR program for patients with cLBP.

Participants needed: 350
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Chronic low back pain, which is pain that persists for at least 3-months and has... [+2]

Red flags- recent (past month) worsening of pain, unexplained fever, unexplained... [+3]

Status: Not yet recruiting

Substance Use Prevention for Recently Displaced Adults - SUPRA (R33) RCT

This study is a randomized controlled trial among 144 internally displaced people to determine the feasibility, acceptability, and preliminary effectiveness of a single-session Acceptance of Commitment Therapy (ACT) group therapy on preventing or reducing substance use behaviors.

Participants needed: 144
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Jun 29, 2026Locations: 1
Eligibility criteria

Age 18 or over [+3]

Self-reported diagnosis of a substance use disorder [+1]

Status: Recruiting

Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries

Animal assisted therapy (AAT) with dogs has been shown to be beneficial for a wide range of patients with both acute and chronic illnesses, including spinal cord injuries, heart failure, myocardial infarctions, strokes, cancer, post-traumatic stress disorder, and depression. Studies have also demonstrated that even in healthy adults, the presence of dogs is associated with physiologic changes such as increased pain threshold, decreased blood pressure, and decreased heart rate. However, few studies have investigated the role of AAT in the post-operative course in adults. This study will investigate the impact of therapy dog visits on pain and anxiety scores for trauma patients at Boston Medical Center (BMC).

Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Jun 16, 2026Locations: 1
Eligibility criteria

Patients admitted to the Trauma and Acute Care Surgery (TACS) service following... [+2]

Fear of dogs, allergy to dogs [+3]

Status: Recruiting

Improving Mental Health in Forcibly Displaced Populations

This project aims to improve mental health support for Venezuelan migrants living in Lima, Peru, who often face challenges like anxiety, depression, and post-traumatic stress disorder (PTSD). Since 2015, millions of Venezuelans have fled their country due to a severe humanitarian crisis, including extreme inflation, food shortages, and political unrest. Many of these individuals now live in Peru, where they struggle to access mental health services. A new type of intervention that is both evidence-based and culturally adapted to meet the specific needs of Venezuelan migrants is the focus of this research. The intervention is designed to be delivered by trained lay providers-people from the community who have received special training but are not professional mental health workers. The intervention consists of 6 to 12 weekly online sessions, each lasting about an hour. These sessions will cover various therapeutic techniques, including cognitive restructuring (changing negative thought patterns), behavioral activation (encouraging positive activities), and emotional regulation (managing feelings). The sessions will be conducted remotely, allowing participants to join from the comfort of their homes.This approach is intended to make mental health care more accessible and relatable for migrants, who may feel more comfortable receiving help from someone who understands their cultural background and experiences.

Participants needed: 90
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: May 28, 2026Locations: 1
Eligibility criteria

have Venezuelan nationality [+5]

Suicidal ideation: "When someone feels as upset as you do, they may have thought... [+2]

Status: Recruiting

Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care

In this pilot study a new kind of music therapy will be created and tested to help prevent confusion, called delirium, that can happen in the hospital. This can affect people with brain diseases like Alzheimer's disease and Parkinson's disease. Each of the anticipated 30 participants will have up to five music therapy sessions. The sessions will be made just for them and may include live music, playing instruments, or listening to recorded music. Surveys will be used to learn how easy the therapy is to do in the hospital and what people think about how helpful the sessions may be for future patients.

Participants needed: 30
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Apr 1, 2026Locations: 1
Eligibility criteria

Admitted as inpatient to Boston Medical Center. [+6]

Admitted to observation status (as these patients would not be expected to remai... [+7]

Status: Recruiting

PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study

The US opioid overdose epidemic has been accompanied by an increase in human immunodeficiency (HIV) among persons who inject drugs. HIV pre-exposure prophylaxis (PrEP) is an FDA approved medication taken daily orally by individuals who are HIV negative, but who are at increased risk for HIV. In order to obtain PrEP, a prescription is needed. Before being prescribed HIV PrEP, it is recommended by the Centers for Disease Control and Prevention (CDC) to obtain an HIV test first. Although home HIV self-test kits are recommended by the CDC and are locally available, uptake remains low. CHORUS+ (Comprehensive HIV, Hepatitis C, and Opioid Use Disorder Response to the Unaddressed Syndemic +) is a theory-based, peer-delivered, mobile phone-supported intervention focused on enhancing uptake and adherence to HIV PrEP (primary outcome), and continuation of MOUD (secondary outcome) among persons who inject opioids. At recruitment, the intervention will include HIV self-testing, rapid initiation of PrEP and MOUD, and 6-month peer recovery coaching (PRC) to support adherence to these medications. This research study seeks to determine the efficacy of a novel intervention to increase the uptake of evidence-based measures to prevent HIV and treat opioid use disorder. The efficacy of this multi-site, two-arm randomized control trial of CHORUS+ and usual care \[passive referral\]. This study is not testing the efficacy of PrEP or HIV home testing which is already known. In addition the investigators will determine the influence of HIV self-testing on PrEP uptake and adherence. In the CHORUS+/ intervention arm, there will be a baseline in-person session with the participant to encourage uptake of PrEP and MOUD using motivational interviewing (MI).

Participants needed: 284
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Medical CenterUpdated: Apr 6, 2026Locations: 2
Eligibility criteria

Injected opioids within the past 6 months (by self-report) [+5]

Persons with previous HIV diagnosis (by self-report; confirmed via HIV test resu... [+3]